Millennium Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Millennium Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.8M	Buy	25,400 +9,900	+64%	+$1.73M	﹤0.01%	2993
2025 Q4	$2.63M	Buy	+15,500	New	+$2.38M	﹤0.01%	3700
2025 Q3	–	Sell	-25,000	Closed	-$2.65M	–	6251
2025 Q2	$2.65M	Buy	+25,000	New	+$2.72M	﹤0.01%	3631
2025 Q1	–	Sell	-20,200	Closed	-$2.49M	–	6139
2024 Q4	$2.49M	Buy	20,200 +200	+1%	+$23.6K	﹤0.01%	3451
2024 Q3	$2.23M	Buy	+20,000	New	+$2.19M	﹤0.01%	3611
2024 Q2	–	Sell	-1,700	Closed	-$205K	–	6227
2024 Q1	$205K	Sell	1,700 -28,300	-94%	-$3.47M	﹤0.01%	5367
2023 Q4	$3.69M	Hold	30,000	–	–	﹤0.01%	3053
2023 Q3	$3.88M	Buy	+30,000	New	+$4M	﹤0.01%	2952
2022 Q2	–	Sell	-75,300	Closed	-$11.7M	–	7223
2022 Q1	$11.7M	Buy	+75,300	New	+$10.9M	0.01%	1964
2021 Q3	–	Sell	-50,000	Closed	-$8.88M	–	7021
2021 Q2	$8.88M	Buy	+50,000	New	+$8.66M	0.01%	2061
2020 Q1	–	Sell	-5,000	Closed	-$746K	–	4182
2019 Q4	$746K	Buy	+5,000	New	+$680K	﹤0.01%	3147
2016 Q2	–	Sell	-15,000	Closed	-$1.96M	–	3368
2016 Q1	$1.96M	Buy	+15,000	New	+$1.87M	﹤0.01%	1785
2015 Q1	–	Sell	-2,500	Closed	-$409K	–	3843
2014 Q4	$409K	Buy	+2,500	New	+$415K	﹤0.01%	3142
2014 Q2	–	Sell	-1,700	Closed	-$236K	–	3645
2014 Q1	$236K	Buy	+1,700	New	+$256K	﹤0.01%	3099
2013 Q3	–	Sell	-42,100	Closed	-$2.89M	–	3442
2013 Q2	$2.89M	Buy	+42,100	New	+$2.57M	0.01%	1360

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Millennium Management's JAZZ Position: Q1 2026 in Review

Millennium Management increased its Jazz Pharmaceuticals (JAZZ) stake by 5% in Q1 2026, buying an estimated $10.5M and bringing the position to 1,262,511 shares worth $239M. The position accounts for 0.1% of the portfolio, ranked #174.

Millennium Management first reported a position in JAZZ in Q2 2013 and has held it in 50 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Millennium Management held 1,262,511 shares of Jazz Pharmaceuticals worth $239M as of Q1 2026.
Millennium Management bought 59,800 Jazz Pharmaceuticals shares in Q1 2026, an estimated $10.5M.
Jazz Pharmaceuticals made up 0.1% of Millennium Management's portfolio in Q1 2026, its #174 holding.
Millennium Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 50 quarters since.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.